+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs



The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs



Journal of Molecular Endocrinology 11(1): 37-47



The peroxisome proliferator-activated receptor (PPAR) is a member of the steroid hormone receptor superfamily and is activated by a variety of fibrate hypolipidaemic drugs and non-genotoxic rodent hepatocarcinogens that are collectively termed peroxisome proliferators. A key marker of peroxisome proliferator action is the peroxisomal enzyme acyl CoA oxidase, which is elevated about tenfold in the livers of treated rodents. We have previously shown that a peroxisome proliferator response element (PPRE) is located 570 bp upstream of the rat peroxisomal acyl CoA oxidase gene and that PPAR binds to it. We show here that the retinoid X receptor (RXR) is required for PPAR to bind to the PPRE, and that the RXR ligand, 9-cis retinoic acid, enhances PPAR action. Retinoids may therefore modulate the action of peroxisome proliferators and PPAR may interfere with retinoid action, perhaps providing one mechanism to explain the toxicity of peroxisome proliferators. We have also shown that a variety of hypolipidaemic drugs and fatty acids can activate PPAR. This supports the suggestion that the physiological role of PPAR is to regulate fatty acid homeostasis, and provides further evidence that PPAR is the target of the fibrate class of hypolipidaemic drugs. Finally, we have demonstrated that a metabolically stabilized fatty acid is a potent PPAR activator, suggesting that fatty acids, or their acyl CoA derivatives, may be the natural ligands of PPAR.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 047697664

Download citation: RISBibTeXText

PMID: 8240670

DOI: 10.1677/jme.0.0110037


Related references

Xenopus peroxisome proliferator activated receptors: Genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids. Journal of Steroid Biochemistry & Molecular Biology 47(1-6): 65-73, 1993

Induction of the fatty acid transport protein 1 and acyl-CoA synthetase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target. Journal of Biological Chemistry 275(17): 12612-12618, 2000

Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective retinoids suggests that the peroxisome proliferator-activated receptor-retinoid (times) receptor heterodimer is their molecular target. The Journal of Biological Chemistry 275(17): 612-18, 2000

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proceedings of the National Academy of Sciences of the United States of America 90(6): 2160-2164, 1993

Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360(9343): 1410-1418, 2002

Dual DNA-binding specificity of peroxisome-proliferator-activated receptor controlled by heterodimer formation with retinoid X receptor a. Biochemical Journal 353(2): 193-198, 2001

Dual DNA-binding specificity of peroxisome-proliferator-activated receptor gamma controlled by heterodimer formation with retinoid X receptor alpha. Biochemical Journal 353(Pt 2): 193-198, 2001

Attenuation of colon inflammation through activators of the retinoid X receptor /peroxisome proliferator-activated receptor gamma heterodimer A basis for new therapeutic strategies. Journal of Experimental Medicine 193(7): 827-838, 2001

Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator-Activated Receptor (Ppar) Heterodimer: A Basis for New Therapeutic Strategies. Journal of Experimental Medicine 193(7): 827-838, 2001

Argan oil prevents down-regulation induced by endotoxin on liver fatty acid oxidation and gluconeogenesis and on peroxisome proliferator-activated receptor gamma coactivator-1α, (PGC-1α), peroxisome proliferator-activated receptor α (PPARα) and estrogen related receptor α (ERRα). Biochimie Open 1: 51-59, 2015

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. Journal of Experimental Medicine 193(7): 827-838, 2001

The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism. Molecular Endocrinology 20(1): 65-79, 2006

Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer. Cancer Research 64(10): 3701-3713, 2004

Peroxisome Proliferator-activated Receptor (PPAR)-2 Controls Adipocyte Differentiation and Adipose Tissue Function through the Regulation of the Activity of the Retinoid X Receptor/PPARg Heterodimer. The Journal of Biological Chemistry 282(52): 738-46, 2007

A peroxisome proliferator-activated receptor gamma-retinoid X receptor heterodimer physically interacts with the transcriptional activator PAX6 to inhibit glucagon gene transcription. Molecular Pharmacology 73(2): 509-517, 2008